NASDAQ:BLFS BioLife Solutions (BLFS) Stock Price, News & Analysis $26.59 +0.68 (+2.62%) Closing price 04:00 PM EasternExtended Trading$26.59 0.00 (0.00%) As of 06:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About BioLife Solutions Stock (NASDAQ:BLFS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BioLife Solutions alerts:Sign Up Key Stats Today's Range$26.17▼$27.4250-Day Range$20.64▼$26.7452-Week Range$19.10▼$29.55Volume372,572 shsAverage Volume366,176 shsMarket Capitalization$1.27 billionP/E RatioN/ADividend YieldN/APrice Target$31.29Consensus RatingModerate Buy Company Overview BioLife Solutions (NASDAQ:BLFS) specializes in biopreservation and cold chain workflow solutions for cell and gene therapies, regenerative medicine and other advanced biologics. The company develops and markets proprietary cryopreservation media and technology platforms designed to maintain cell viability and functionality during processing, storage and transport. BioLife’s product portfolio addresses critical steps in the manufacturing and distribution of cell-based products, helping life science researchers and biopharmaceutical manufacturers protect and preserve living cells. The company’s flagship offerings include CryoStor, a family of serum-free cryopreservation media; HypoThermosol, a hypothermic storage solution for short-term cell and tissue preservation; and the ThawSTAR system, an automated cell thawing instrument that delivers controlled and reproducible warming of frozen cell therapies. In addition to its core media and instrumentation, BioLife provides technical support, training and validation services to help customers integrate its products into regulated processes and meet GMP-compliance requirements. Headquartered in Bothell, Washington, BioLife Solutions serves a global customer base spanning academic research centers, contract development and manufacturing organizations (CDMOs) and commercial biopharmaceutical companies. The company has established distribution channels in North America, Europe and Asia to support the growing demand for standardized, clinical-grade preservation solutions. BioLife’s management team is led by President and Chief Executive Officer Warren T. Thompson, whose experience in the life sciences industry has guided strategic product development and expansion initiatives. Through continuous innovation in biopreservation technologies, BioLife Solutions aims to enable the safe and reliable delivery of next-generation cell therapies worldwide.AI Generated. May Contain Errors. Read More BioLife Solutions Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks51st Percentile Overall ScoreBLFS MarketRank™: BioLife Solutions scored higher than 51% of companies evaluated by MarketBeat, and ranked 584th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingModerate Buy Consensus RatingBioLife Solutions has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on 7 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialBioLife Solutions has a consensus price target of $31.29, representing about 17.7% upside from its current price of $26.59.Amount of Analyst CoverageBioLife Solutions has only been the subject of 4 research reports in the past 90 days.Read more about BioLife Solutions' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for BioLife Solutions are expected to grow in the coming year, from ($0.30) to ($0.13) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of BioLife Solutions is -221.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of BioLife Solutions is -221.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBioLife Solutions has a P/B Ratio of 3.54. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about BioLife Solutions' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.20% of the outstanding shares of BioLife Solutions have been sold short.Short Interest Ratio / Days to CoverBioLife Solutions has a short interest ratio ("days to cover") of 7.9.Change versus previous monthShort interest in BioLife Solutions has recently decreased by 0.25%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBioLife Solutions does not currently pay a dividend.Dividend GrowthBioLife Solutions does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted8.20% of the outstanding shares of BioLife Solutions have been sold short.Short Interest Ratio / Days to CoverBioLife Solutions has a short interest ratio ("days to cover") of 7.9.Change versus previous monthShort interest in BioLife Solutions has recently decreased by 0.25%, indicating that investor sentiment is improving. News and Social Media2.1 / 5News Sentiment0.86 News SentimentBioLife Solutions has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for BioLife Solutions this week, compared to 5 articles on an average week. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, BioLife Solutions insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $23,981,317.00 in company stock.Percentage Held by InsidersOnly 2.20% of the stock of BioLife Solutions is held by insiders.Percentage Held by Institutions93.24% of the stock of BioLife Solutions is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about BioLife Solutions' insider trading history. Receive BLFS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioLife Solutions and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BLFS Stock News HeadlinesSarah Aebersold Sells 714 Shares of BioLife Solutions (NASDAQ:BLFS) StockSeptember 18, 2025 | insidertrades.comInsider Selling: BioLife Solutions (NASDAQ:BLFS) Insider Sells 511 Shares of StockSeptember 16, 2025 | insidertrades.comU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised to benefit from this massive shift inside my Bull Run Millionaire Blueprint.October 3 at 2:00 AM | Crypto 101 Media (Ad)Strong week for BioLife Solutions (NASDAQ:BLFS) shareholders doesn't alleviate pain of five-year lossOctober 2 at 6:47 PM | finance.yahoo.comBioLife: Back To Basics Is Getting Traction (Rating Upgrade)October 1 at 10:07 AM | seekingalpha.comAnalysts Set BioLife Solutions, Inc. (NASDAQ:BLFS) Target Price at $31.29September 28, 2025 | americanbankingnews.comBioLife Solutions management to meet virtually with KeyBancSeptember 25, 2025 | msn.comBioLife Solutions Reports Strong Q2 Growth Amid ChallengesAugust 13, 2025 | msn.comSee More Headlines BLFS Stock Analysis - Frequently Asked Questions How have BLFS shares performed this year? BioLife Solutions' stock was trading at $25.96 on January 1st, 2025. Since then, BLFS stock has increased by 2.4% and is now trading at $26.59. How were BioLife Solutions' earnings last quarter? BioLife Solutions, Inc. (NASDAQ:BLFS) released its quarterly earnings data on Thursday, August, 7th. The medical equipment provider reported ($0.33) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by $0.31. The medical equipment provider had revenue of $25.42 million for the quarter, compared to analysts' expectations of $23.71 million. BioLife Solutions had a negative net margin of 5.39% and a positive trailing twelve-month return on equity of 0.16%. Read the conference call transcript. How do I buy shares of BioLife Solutions? Shares of BLFS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of BioLife Solutions own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioLife Solutions investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Visa (V). Company Calendar Last Earnings8/07/2025Today10/03/2025Next Earnings (Estimated)11/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:BLFS CIK834365 Webwww.biolifesolutions.com Phone(425) 402-1400Fax425-402-1433Employees440Year Founded1987Price Target and Rating Average Price Target for BioLife Solutions$31.29 High Price Target$33.00 Low Price Target$30.00 Potential Upside/Downside+17.7%Consensus RatingModerate Buy Rating Score (0-4)2.89 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)($0.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$20.18 million Net Margins-5.39% Pretax Margin-18.34% Return on Equity0.16% Return on Assets0.14% Debt Debt-to-Equity RatioN/A Current Ratio4.43 Quick Ratio3.45 Sales & Book Value Annual Sales$82.25 million Price / Sales15.49 Cash Flow$0.13 per share Price / Cash Flow211.49 Book Value$7.52 per share Price / Book3.54Miscellaneous Outstanding Shares47,900,000Free Float46,851,000Market Cap$1.27 billion OptionableOptionable Beta1.95 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:BLFS) was last updated on 10/3/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredChina’s message to TrumpPorter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.